on 11 Jan 2024
Last Applicant/ Owned by
INFLARX GMBH
Winzerlaer Str. 207745 Jena
DE
Serial Number
2213271 filed on 01st Aug 2022
Correspondent Address
SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO
ONTARIO
CA
M5X1G5
Trademark usage description
antibodies, specifically monoclonal antibodies, namely monoclonal antibodies targeting acute and chronic inflammation.11
CIPO Classification Code
Nice
2213271
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 236 on 07th Feb 2024 | Partial Withdrawal - Madrid Protocol |
Submitted for opposition 22 on 11th Jan 2024 | Search Recorded |
Submitted for opposition 20 on 11th Jan 2024 | Examiner's First Report |
Submitted for opposition 223 on 11th Jan 2024 | Total Provisional Refusal |
Submitted for opposition 256 on 31st Jul 2023 | Notification of Possible Opposition Sent |
Submitted for opposition 31 on 01st Oct 2022 | Formalized |
Submitted for opposition 1 on 01st Oct 2022 | Created |
Submitted for opposition 257 on 29th Sep 2022 | Designation Notification - Madrid Protocol |
Submitted for opposition 228 on 01st Aug 2022 | International Registration |
Submitted for opposition 30 on 01st Aug 2022 | Filed |